BMY Bristol-Myers Squibb Company

58.83USD+0.84%Mkt Cap: 120.25B USDP/E: 13.04

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovasc…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap120.25B USD
Enterprise Value151.48B USD
Revenue (TTM)50.03B USD
Gross Profit34.26B USD
Net Income (TTM)7.05B USD
Revenue/Share24.54 USD
Last Price58.83 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees32.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)13.04
P/E (Forward)8.79
PEG16.33
EV/EBITDA8.30
EV/Revenue3.03
P/S2.40
P/B5.14
EPS (TTM)4.51 USD
EPS (Forward)6.70 USD
52W Range
45.2758% of range68.64
52W High68.64 USD
52W Low45.27 USD
Profitability
Gross Margin71.08%
Oper. Margin32.37%
EBITDA Margin36.46%
Profit Margin14.64%
ROE38.19%
ROA7.83%
ROIC18.88%
ROCE20.60%
Growth
Revenue Growth6.90%
Earnings Growth-2.80%
Cash Flow & Leverage
Operating CF14.16B USD
CapEx (TTM)1.31B USD
FCF Margin12.72%
FCF Yield5.29%
Net Debt32.23B USD
Net Debt/EBITDA1.77
Net Debt/FCF5.06
Balance Sheet
Debt/Equity2.55
Current Ratio1.59
Quick Ratio1.36
Book Value/Sh11.45 USD
Cash/Share6.16 USD
Dividends
Fwd Div Rate2.52 USD
Trail. Div Rate2.52 USD
Div. Yield4.32%
5Y Avg Yield3.86%
Payout Ratio55.88%
Ex-Div DateOct 2, 2026
Pay DateNov 2, 2026
Splits
Last Split1000000:951777
Split DateAug 7, 2001
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)65.25 USD
Upside (mean)+10.9%
Target Range40.00 USD – 80.00 USD
40.00+10.9% to mean80.00
# Analysts24
Ownership
Shares Out.2.04B
Float2.04B
Insiders0.10%
Institutions85.36%
Short Interest
Short Ratio3.7d
Short % Float2.29%
Short % Out.2.29%
Shares Short46.85M
Short (prev mo.)45.85M
Technical
SMA 5061.66 (-4.6%)
SMA 20060.43 (-2.6%)
Beta0.19
S&P 52W Chg12.00%
Avg Vol (30d)10.89M
Avg Vol (10d)9.50M
Technical Indicators
RSI (14)39.6
MACD-0.4279
MACD Signal0.0374
MACD Hist.-0.4653
BB Upper64.86 USD
BB Middle61.82 USD
BB Lower58.78 USD
BB Width9.83%
ATR (14)1.792 USD
Vol Ratio (20d)1.20x

About Bristol-Myers Squibb Company (NYSE: BMY)

›

Bristol-Myers Squibb Company (NYSE: BMY) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector, and reports about 32,500 employees.

The shares were at 58.83 USD on 20 November 2026, up 28.5% over 52 weeks. Its 52-week range is 45.27 USD to 68.64 USD: the price is 14.3% below the high and 30.0% above the low.

At a market capitalisation of 120.25B USD, it trades at 13.0 times trailing earnings and 8.8 times forward earnings. The median trailing P/E of its 19 largest Drug Manufacturers - General peers is 25.9, a discount of 50% for BMY. It pays a dividend yielding 4.32% (it pays out 56% of its earnings), against a median of 2.45% among the dividend payers in that peer group.

Bristol-Myers Squibb Company reports return on equity of 38.2%, an operating margin of 32.4% and revenue up 6.9% year over year.

Its debt exceeds its cash by 32.23B USD, a debt-to-equity ratio of 2.55. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 24 analysts cover the stock, with an average rating of Hold; their mean price target of 65.25 USD is 10.9% above the current price. The next earnings report is expected on 4 February 2027.